| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 7 |
| 1 | BELANTAMAB MAFODOTIN | 7 |
| 2 | INFLIXIMAB | 6 |
| 3 | PREDNISONE | 5 |
| 4 | ALBUTEROL SULFATE | 4 |
| 5 | DUPILUMAB | 4 |
| 6 | ALENDRONATE SODIUM | 3 |
| 7 | AMLODIPINE | 3 |
| 8 | ASPIRIN | 3 |
| 9 | ASPIRIN 325 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELANTAMAB MAFODOTIN | 7 | 0.0023 |
| 1 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 2 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 3 | LOTILANER OPHTHALMIC SOLUTION | 2 | 0.0005 |
| 4 | CARBOXYMETHYLCELLULOSE SODIUM | 2 | 0.0004 |
| 5 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 6 | DEUCRAVACITINIB | 1 | 0.0003 |
| 7 | ACLIDINIUM BROMIDE | 2 | 0.0003 |
| 8 | BELUMOSUDIL | 1 | 0.0003 |
| 9 | LARONIDASE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Ectoparasiticide [EPC] | 2 | 0.0005 |
| 2 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 4 | Barbiturate [EPC] | 1 | 0.0001 |
| 5 | Aluminum Complex [EPC] | 2 | 0.0001 |
| 6 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 9 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |